Inside ImmunoPrecise Antibodies Ltd $IPA.: Revolutionizing Research W/ Integrative Technologies & AI
Benzinga
Benzinga
  • 2 months ago
Dr. Jennifer Bath, CEO & President of ImmunoPrecise Antibodies Ltd., was recently interviewed by Benzinga.

ImmunoPrecise is a biotherapeutic research company and is a leader in antibody discovery services, utilizing complex artificial intelligence technologies. The company integrates cutting-edge tech and AI in its propriety platform, LENSai.

The revolutionary technology pools together data and disparate knowledge across scientific literature – knowledge that may have been previously siloed – to make insights that would not be possible otherwise.
Recommended
0:33
I
Up next
New Research: Coronavirus Antibodies In Over 99% Of Recovered Patients
Wochit Entertainment
0:33
New Research- Coronavirus Antibodies In Over 99% Of Recovered Patients
Best Oddly Satisfying
0:44
Duke Researchers Create Antibodies To Attack Cancer Cells
NowThis
0:31
CrowdFinch Technologies Pvt Ltd
Metatube
5:22
Unveiling the Secrets of Rummy App Development: Live Demo | ColourMoon Technologies Pvt Ltd | Tambola App Development in Hyderabad
ColourMoon Technologies
5:51
Kfin Technologies Ltd
Vijayy
Benzinga
0:40
Maryland Teacher Faces Criminal Charges for Spreading an AI-Generated Fake Recording of the Principal Making Racist Comments
Benzinga
0:27
Arizona Grand Jury Indicts 18 Individuals Involved in Submitting Fake Elector Documents
Benzinga
0:46
ByteDance Unlikely to Sell TikTok, Preferring Shutdown in the US to Parting Ways with Its Key Algorithm
Benzinga
0:35
Google Parent Alphabet Announces $70 Billion Stock Buyback Program After Stellar Q1 Results
Benzinga
0:38
Analysts Predict Chevron and ExxonMobil Will Report Lower Q1 Profits Despite Rising Oil Prices
Benzinga
0:39
Meta Stock Plummets 15% as Market Reacts to Increased AI Spending
Benzinga
Featured channels
More from
EarthX
More from
TIME
More from
Insider
More from
What's Trending
More from
Entrepreneur
More from
SportsGrid